Who are the Valves in Pharmaceutical Market Top Vendors and What are Their Offerings?
Valves in Pharmaceutical Companies Overview
| Companies | Headquarters | Pharmaceutical Valves |
| Emerson Electric Co. | St. Louis, U.S. | Automated and manually controlled quarter-turn valves and sanitary Fisher control valves |
| Alfa Laval AB | Lund, Sweden | Hygienic diaphragm valves and UltraPure butterfly valves |
| Bürkert Fluid Control Systems | Ingelfingen, Germany | Aseptic diaphragm valves and solenoid control valves |
| Flowserve Corporation | Irving, U.S. | Aseptic control valves and sanitary butterfly valves |
| Spirax-Sarco Engineering plc | Cheltenham, UK | STERI-TROL cleans services control valves and the M70i sanitary ball valve |
| GEMÜ Group | Ingelfingen, Germany | Single-use diaphragm valves and sanitary aseptic valves |
| Crane Co. | Stamford, U.S. | Saunders HC4 Aseptic diaphragm valves and high-performance butterfly valves |
| Swagelok Company | Solon, U.S. | High-purity diaphragm-sealed valves and bellows-sealed valves |
| Parker-Hannifin Corporation | Cleveland, U.S. | Fluoropolymer valves, sanitary process valves, and high-purity solenoid valves |
| Velan Inc. | Montreal, Canada | High-pressure stainless steel and alloy valves |
Valves in Pharmaceutical Market Value Chain Analysis
R&D
- The R&D of the valves in the pharmaceutical focus on smart automation, advanced material science, and single-use technology.
- Key players: Bürkert Fluid Control Systems, Alfa Laval AB, Crane Co.
Clinical Trials and Regulatory Approvals
- The regulatory validation process, leak-proof performance, material biocompatibility, and sterility standards are evaluated in the clinical trials and regulatory approvals of the valves in the pharmaceutical industry.
- Key players: Bürkert Fluid Control Systems, Alfa Laval AB, Crane Co.
Patient Support and Services
- 24/7 technical assistance, rapid spare parts delivery, and predictive maintenance are provided in the patient support and services for the pharmaceutical valves.
- Key players: Bürkert Fluid Control Systems, Alfa Laval AB, Spirax-Sarco Engineering plc.
Market Growth
The global valves in pharmaceutical market size was estimated at USD 2.48 billion in 2025 and is predicted to increase from USD 2.62 billion in 2026 to approximately USD 4.37 billion by 2035, expanding at a CAGR of 5.84% from 2026 to 2035.
Everything you need to monitor the mRNA CDMO market, organized and accessible - Access the Dashboard
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
